Showing results (431-440 of 582) with videos related to
Sort By:
Pageof 59
Journal of Geriatric Psychiatry and Neurology|June 7, 2015
A Pilot Study of a Cognitive-Behavioral Treatment for Anxiety and Depression in Patients With Parkinson DiseaseJessica S Calleo, Amber B Amspoker, Aliya I Sarwar, et al.Brain : a Journal of Neurology|November 16, 2017
Excessive burden of lysosomal storage disorder gene variants in Parkinson's diseaseLaurie A Robak, Iris E Jansen, Jeroen van Rooij, et al.Parkinsonism & Related Disorders|July 31, 2020
Understanding the relationship between freezing of gait and other progressive supranuclear palsy featuresSaba Rezvanian, Irene Litvan, David Standaert, et al.BMC Neurology|November 8, 2011
Rationale and design of a prospective study: Cervical Dystonia Patient Registry for Observation of OnaBotulinumtoxinA Efficacy (CD PROBE)Joseph Jankovic, Charles H Adler, P David Charles, et al.Journal of Parkinson'S Disease|January 14, 2020
EASE LID 2: A 2-Year Open-Label Trial of Gocovri (Amantadine) Extended Release for Dyskinesia in Parkinson's DiseaseCaroline M Tanner, Rajesh Pahwa, Robert A Hauser, et al.Neuroscience Letters|August 25, 2012
Mutation screening of the HTR2B gene in patients with Tourette syndromeYi Guo, Xiong Deng, Joseph Jankovic, et al.Parkinsonism & Related Disorders|September 24, 2013
Randomized trial of IPX066, carbidopa/levodopa extended release, in early Parkinson's diseaseRajesh Pahwa, Kelly E Lyons, Robert A Hauser, et al.Surgical Neurology|June 3, 2008
Five-year follow-up of unilateral posteroventral pallidotomy in Parkinson's diseaseAdriana M Strutt, Eugene C Lai, Joseph Jankovic, et al.Movement Disorders Clinical Practice|July 17, 2018
Injectable DaxibotulinumtoxinA in Cervical Dystonia: A Phase 2 Dose-Escalation Multicenter StudyJoseph Jankovic, Daniel Truong, Atul T Patel, et al.Neuroscience Letters|October 19, 2010
LINGO1 rs9652490 variant in Parkinson disease patientsYi Guo, Joseph Jankovic, Zhi Song, et al.Pageof 59